The voltage-dependent L-type Ca
2+ channel plays a key role in the spacial and temporal regulation of Ca
2+. In cardiac excitation-contraction coupling, Ca
2+-induced Ca
2+ release (CICR) from ryanodine receptors (RyRs), triggered by Ca
2+ entry through the nearby L-type Ca
2+ channel, induces the Ca
2+-dependent inactivation (CDI) of the Ca
2+ channel. We demonstrated that the CICR-dependent CDI of L-type Ca
2+ channels, under control of the privileged cross-signaling between L-type Ca
2+ channels and RyRs, plays important roles for monitoring and tuning the SR Ca
2+ content via changes of AP waveform and the amount of Ca
2+-influx during AP in ventricular myocytes. L-type Ca
2+ channels are modulated by the binding of Ca
2+ channel antagonists and agonists to the pore-forming α
1C subunit. We identified Phe
1112 and Ser
1115 in the pore-forming IIIS5-S6 linker region of the α
1C subunit as critical determinants of the binding of dihydropyridines (DHP). Interestingly, double mutant Ca
2+ channel (F1112A/S1115A) failed to discriminate between a DHP Ca
2+ channel agonist and antagonist stereoisomers. We proposed that Phe
1112 and Ser
1115 in the pore-forming IIIS5-S6 linker region is required for the stabilization of the Ca
2+ channel in the open state by Ca
2+ channel agonists and further proposed a novel model for the DHP-binding pocket of the α
1C subunit. These integrative studies on the gating regulation of cardiac L-type Ca
2+ channels will provide the molecular basis for the pharmacology of Ca
2+ channel modulators.
View full abstract